Browsing Category
Medicine
Pfizer: Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant…
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Pfizer Inc. (NYSE: PFE), today announced that the parties have completed the collaboration transaction between the two companies. The transaction agreements, including Pfizer’s!-->…
Pfizer: Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo…
Pfizer Inc. (NYSE: PFE) and Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced an exclusive four-year research collaboration focused on in vivo base!-->…
Pfizer: Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery…
Pfizer Inc. (NYSE: PFE) and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, today announced they have entered into a Development and Option!-->…
Pfizer: Positive Top-Line Results of Pfizer’s Phase 3 Study Exploring Coadministration of PREVNAR…
Pfizer Inc. (NYSE:PFE) today announced positive top-line results from a Phase 3 study (B7471026) describing the safety and immunogenicity of PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in 570 adults in the United States 65!-->…
Pfizer: U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic…
Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved CIBINQO® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for the treatment of adults living with!-->…
Pfizer: Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to!-->…
Concern over Rising Incidents of Heart Attacks among Youth
Aligarh: Contrary to popular perception about heart diseases affecting older people, eminent cardiologists turned attention to the rising incidents of heart attacks in the younger population. They expressed grave concerns in a…
Pfizer: U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Ankylosing…
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for XELJANZ® / XELJANZ® XR (tofacitinib) for the treatment of adults with active ankylosing!-->…
Pfizer: EMA Adopts a Positive CHMP Opinion for Pfizer’s and OPKO’s Somatrogon, a Long-Acting…
Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending somatrogon, a once-weekly long-acting recombinant!-->…
Pfizer: Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral…
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) for the treatment of mild-to-moderate COVID-19 in adults!-->…